Navigation Links
The Leukemia & Lymphoma Society Awards $12 Million in Research Grants in Four Critical Areas of Unmet Medical Need
Date:8/23/2012

prevention of anthracycline-related cardiomyopathy 
  • Ruben Niesvizky, M.D., Joan & Sanford I. Weill Medical College of Cornell University, Stem cell alterations in lenalidomide treated myeloma patients 
  • Pavan Reddy, M.D., University of Michigan, Alpha 1-antitypsin as a novel strategy to modulate GVHD 
  • Daniela Salvemini, Ph.D, Saint Louis University, Blocking bortezomib induced painful peripheral neuropathy with FTY720 

    • LLS also announced the awarding of an additional 28 TRP grants, totaling $15.6 million, to scientists working in other areas of blood cancer research.

    "By issuing RFP's LLS is taking a strategic approach to identifying and prioritizing areas of need and directing funding to research that shows the most promise for improving survival and quality of life for patients with these particularly difficult diseases," said Richard Winneker, Ph.D., LLS's SVP, Research.

    About The Leukemia & Lymphoma Society
    The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

    Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. www.lls.org.

    Contact:  Andrea Greif
                  (914) 821-8958 
             
    '/>"/>

    SOURCE The Leukemia & Lymphoma Society
    Copyright©2012 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4

    Related biology technology :

    1. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
    2. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
    3. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
    4. MarketsandMarkets: Chronic Lymphocytic Leukemia Therapeutics Market Worth $2.2 Billion by 2020
    5. MarketsandMarkets: Acute Myeloid Leukemia Therapeutics Market in G8 Countries Worth $1.67 Billion by 2020
    6. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
    7. TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
    8. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
    9. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
    10. How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack
    11. Acute Lymphocytic Leukemia: Impressive Results With the Monoclonal Antibody Blinatumomab in Patients With Refractory Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/19/2013)... Md. , June 19, 2013 Synthetic Biologics, ... the prevention and treatment of serious infectious diseases, announced today ... 6 th Annual OneMedForum New York Conference on Thursday, ... New York City . Mr. Riley is scheduled to ... webcast of Synthetic Biologics, presentation can be accessed by logging ...
    (Date:6/19/2013)... Bayer CropScience will honor Illinois beekeeper ... Community Leadership Award. The award will be announced at ... Washington, D.C., an event where supporters of pollinator health ... supply. , The Bayer Bee Care Community Leadership ... the honey bee colony to benefit their community. Applicants ...
    (Date:6/19/2013)... (PRWEB) June 19, 2013 BioConvergence ... the speaking faculty at 2013’s BioLogistics Summit in ... conference, coordinated by Cold Chain IQ and IQPC, ... This “complexity” is, in part, attributed to current ... , “Implicit within these trends is an increase ...
    (Date:6/19/2013)... MN (PRWEB) June 19, 2013 Express ... abuse tests, today announced that it has received Class ... market and sell its DrugCheck® NxStep Onsite Drug ... use of the rapid screening device in near-patient settings, ... Drug Screen Cup received Health Canada Class III approval ...
    Breaking Biology Technology:Synthetic Biologics to Present at OneMedForum New York 2013 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
    ... the U.S. Department of Energy,s Argonne National Laboratory, will ... 138 on Nanoalloys: From Theory to Application, to be ... in the United Kingdom. , The Faraday Discussions are ... have been of enormous influence in reviewing the current ...
    ... Stevens Institute of Technology and NACE International, ... Section, will host the Winter 2007 Corrosion Symposium: ... Charles V. Schaefer, Jr. School of Engineering & ... Keith Sheppard, a professor materials engineering, will welcome ...
    ... splinting and bracing technology, ST. PAUL, ... of St. Paul, Minn., and Product Innovations, ... announce the launch of Exos Corporation, a ... innovative orthopedic,support devices. Exos will focus ...
    Cached Biology Technology:Enova Medical Launches Exos Corporation 2
    (Date:6/19/2013)... specifically for human consumption qualifies as a gluten-free cereal ... (CD), scientists have confirmed in a study published in ... , Joyce Irene Boye and colleagues point out ... States alone have CD. They develop gastrointestinal and other ... that contain gluten-related proteins. Boye,s team sought to expand ...
    (Date:6/19/2013)... ITHACA, N.Y. A Cornell University study offers further ... 4 million to 6 million years ago was profoundly ... in turning genes on and off. , The study, ... evidence for a 40-year-old hypothesis that regulation of genes ... is little difference between humans and chimps in the ...
    (Date:6/19/2013)... world-leading provider of scientific, technical and medical information products ... a new open access journal, GeoResJ . ... earth and planetary science journals portfolio has its first ... a forum for rapid publication of top research within ... co-edited by six Executive Editors, each covering a different ...
    Breaking Biology News(10 mins):New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3
    ... by the journal Nature until January 30, 1 PM Eastern ... Research Institute have identified a pathway in the brain that ... The findings suggest a new target for anti-smoking therapies. ... issue of the journal Nature . In the ...
    ... University of California, San Diego School of Medicine ... cognitive defects associated with a rare childhood neurological ... to be defective in LND are known to ... Alzheimer,s and Parknson,s diseases, suggesting common causes of ...
    ... statistically significant level to their sons, and the same is ... it does not seem to impact on the probability of ... not affect his daughter", Loureiro, a researcher at the Universidade ... the study, tells SINC. The research, which has been ...
    Cached Biology News:Scripps Research scientists reveal key mechanism governing nicotine addiction 2Scripps Research scientists reveal key mechanism governing nicotine addiction 3Genetic clues to compulsive, self-injurious behavior in rare childhood disorder 2Genetic clues to compulsive, self-injurious behavior in rare childhood disorder 3Smoking habits are transmitted from mother to daughter and father to son 2
    ... Triple-angle light scattering detector for ... digital signal processing hardware for two ... UV detectors. Also contains an analog ... interfacing to strip chart recorders. Includes ...
    ...
    MAb to Verotoxin II (SLT-2a) Verotoxin II (Shiga-like) A subunit (SLT-2a)...
    ... BIP-NC H-IPMIK-OH ... PROTECT FROM LIGHT. HYGROSCOPIC. PACKAGED UNDER INERT ... Bax-Inhibiting Peptide, V5 (Cat. No. 196810) that ... suppress Bax-mediated apoptosis (~200 μM). Purity: ...
    Biology Products: